Vectivbio Holding Ag Asset Turnover Ratio (VECT), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vectivbio Holding Ag  (NASDAQ: VECT)
 

Vectivbio Holding Ag Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Vectivbio Holding Ag asset turnover ratio, the ability of Vectivbio Holding Ag's assets to generate revenue in the fourth quarter 2022, increased sequentially to 0.11 in the fourth quarter (Dec 31 2022), a new company high.

Within sector 50 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2022 compared to the preceding quarter from 0 to 3894.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VECT Asset Turnover Ratio (Dec 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Asset Change 71.69 % 85.01 % 10.67 % 85.01 % 83.01 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.11 - - - -
VECT's Total Ranking # 3894 # 0 # 0 # 0 # 0
Seq. Asset Change 10.27 % 27.91 % -21.82 % 55.7 % 18.83 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 51
Healthcare Sector # 575
Overall Market # 3894

Asset Turnover Ratio Statistics
High Average Low
0.11 0.11 0.11
(Dec 31 2022)  




VECT Company Profile • Back to VECT Efficiency Comparisons • Compare VECT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022
Innoviva Inc   0.27 $ 322.877  Millions$ 1,201.081  Millions
Dmk Pharmaceuticals Corporation  0.27 $ 4.756  Millions$ 17.828  Millions
Telesis Bio Inc   0.26 $ 183.164  Millions$ 696.375  Millions
Schrodinger Inc   0.26 $ 180.955  Millions$ 689.497  Millions
Pulmonx Corporation  0.26 $ 53.662  Millions$ 207.864  Millions
Standard Biotools Inc   0.26 $ 97.948  Millions$ 379.571  Millions
Veracyte Inc   0.26 $ 296.536  Millions$ 1,150.042  Millions
Esperion Therapeutics Inc   0.25 $ 75.475  Millions$ 301.900  Millions
Ultragenyx Pharmaceutical Inc   0.25 $ 363.329  Millions$ 1,467.144  Millions
Kineta Inc   0.25 $ 4.569  Millions$ 18.511  Millions
Guardant Health Inc   0.25 $ 449.538  Millions$ 1,823.775  Millions
Alpha Teknova Inc   0.24 $ 41.420  Millions$ 169.703  Millions
Arbutus Biopharma Corp  0.24 $ 39.019  Millions$ 162.519  Millions
Mirum Pharmaceuticals Inc   0.24 $ 77.062  Millions$ 323.159  Millions
Jaguar Health Inc   0.24 $ 11.956  Millions$ 50.383  Millions
Procept Biorobotics Corporation  0.24 $ 75.014  Millions$ 316.301  Millions
Novan Inc   0.24 $ 23.682  Millions$ 100.010  Millions
Ionis Pharmaceuticals Inc   0.24 $ 587.367  Millions$ 2,482.768  Millions
Biocorrx Inc   0.24 $ 0.214  Millions$ 0.905  Millions
Quotient Limited  0.24 $ 36.269  Millions$ 153.953  Millions
Palvella Therapeutics Inc   0.23 $ 25.902  Millions$ 111.519  Millions
Co diagnostics Inc   0.23 $ 34.218  Millions$ 150.730  Millions
Q Biomed inc   0.23 $ 0.284  Millions$ 1.256  Millions
Cryoport inc   0.23 $ 237.277  Millions$ 1,050.050  Millions
Ginkgo Bioworks Holdings Inc   0.23 $ 477.706  Millions$ 2,115.490  Millions
Agenus Inc  0.23 $ 98.024  Millions$ 435.014  Millions
Quanterix Corporation  0.22 $ 104.820  Millions$ 468.538  Millions
Twist Bioscience Corporation  0.22 $ 215.790  Millions$ 968.162  Millions
Fortress Biotech Inc   0.22 $ 75.743  Millions$ 347.437  Millions
Adaptive Biotechnologies Corporation  0.22 $ 185.308  Millions$ 851.413  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.